CORTICOSTEROID SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

被引：0
|
作者：
Sandborn, William J.
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Scherl, Ellen J.
Marano, Colleen W.
O'Brien, Christopher D.
Zhang, Hongyan
Johanns, Jewel
Zhou, Yiying
Abreu, Maria T.
Arasaradnam, Ramesh P.
Rowbotham, David
Leong, Rupert W.
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1851
引用
收藏
页码：S1187 / S1188
页数：2
相关论文
共 50 条
  • [11] Efficacy of ustekinumab for ulcerative colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M. T.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 117 - 118
  • [12] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL CLINICAL AND ENDOSCOPY OUTCOMES FROM THE UNIFI LONG-TERM EXTENSION
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Sands, Bruce E.
    Marano, Colleen W.
    GASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1094
  • [13] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study
    Afif, Waqqas
    Arasaradnam, Ramesh P.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 910 - 921
  • [14] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN BIOLOGIC NAIVE, BIOLOGIC NON-FAILURE, AND BIOLOGIC FAILURE POPULATIONS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION
    Sands, Bruce E.
    Sandborn, William J.
    Panaccione, Remo
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Zhou, Yiying
    Peyrin-Biroulet, Laurent
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David
    Arasaradnam, Ramesh P.
    Hisamatsu, Tadakazu
    Abreu, Maria T.
    Danese, Silvio
    Marano, Colleen W.
    GASTROENTEROLOGY, 2020, 158 (06) : S1203 - S1204
  • [15] Efficacy and safety of ustekinumab for Ulcerative Colitis through 4 years in Asian patients: Final results from the sub-population of UNIFI long-term extension
    Hisamatsu, T.
    Kim, H. J.
    Motoya, S.
    Suzuki, Y.
    Ohnishi, Y.
    Marano, C.
    Imai, Y.
    Saadoun, C.
    Zhuo, J.
    Kawamura, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 566 - 568
  • [16] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION
    Abreu, Maria T.
    Sands, Bruce E.
    Leong, Rupert W.
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Zhou, Yiying
    Johanns, Jewel
    Rowbotham, David
    Hisamatsu, Tadakazu
    Arasaradnam, Ramesh P.
    Scherl, Ellen J.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2020, 158 (06) : S1201 - S1201
  • [17] Efficacy and safety of long-term treatment with ustekinumab in moderate-severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extension
    Sands, B. E.
    Abreu, M. T.
    Leong, R. W. L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Zhou, Y.
    Johanns, J.
    Rowbotham, D.
    Hisamatsu, T.
    Arasaradnam, R. P.
    Scherl, E.
    Danese, S.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S476 - S477
  • [18] Corticosteroid Sparing Effects of Ustekinumab Therapy in UC Patients: Results From the UNIFI Program
    Danese, Silvio
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Marano, Colleen
    O'Brien, Christopher
    Zhang, Hongyan
    Oortwijn, Alessandra
    Rowbotham, David
    Leong, Rupert W. L.
    Arasaradnam, Ramesh P.
    Van Assche, Gert
    Sandborn, William J.
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S421 - S421
  • [19] Effect of Ustekinumab Maintenance Therapy on Stool Frequency and Rectal Bleeding Through 2 Years in the UNIFI Phase 3 Study in Ulcerative Colitis
    Abreu, Maria T.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Marano, Colleen
    Zhou, Yiying
    Zhang, Hongyan
    Leong, Rupert W. L.
    Rowbotham, David
    Panaccione, Remo
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S398 - S398
  • [20] Pharmacokinetics and Immunogenicity of Maintenance Therapy With Ustekinumab: 2-Year Results From the UNIFI Long-Term Extension Study
    Adedokun, Omoniyi
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Abreu, Maria T.
    Leong, Rupert W. L.
    Rowbotham, David
    Marano, Colleen
    Zhou, Yiying
    Zhang, Hongyan
    Danese, Silvio
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sandborn, William J.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S437 - S437
12345